Teva competitors & alternatives

Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, providing a wide range of therapeutic solutions to patients worldwide. As a major player in the pharmaceutical manufacturing sector, Teva is frequently evaluated against other industry giants and specialized manufacturers. Professionals and procurement teams often compare Teva to its competitors to assess supply chain reliability, drug portfolio breadth, and cost-effectiveness. Understanding these alternatives is essential for stakeholders looking to optimize their pharmaceutical procurement strategies, ensure consistent drug availability, and leverage the unique strengths of different manufacturers in the highly competitive global healthcare market.

Top Teva competitors

Teva competitors include Sandoz, Viatris, Sun Pharma, Hikma Pharmaceuticals and Amneal Pharmaceuticals.

12 Alternatives

Sandoz

Generic Pharmaceutical ManufacturerEnterprise

Sandoz competes with Teva in the global generic drug market, offering a vast portfolio of biosimilars and off-patent medications. While Teva maintains a massive footprint in complex specialty medicines, Sandoz differentiates itself through a highly streamlined supply chain and a focused strategy on high-volume, cost-effective generic distribution for healthcare providers.

Viatris

Global Healthcare CompanyEnterprise

Viatris competes with Teva in the development and manufacturing of diverse therapeutic treatments. Unlike Teva, which leverages deep expertise in CNS and respiratory specialty drugs, Viatris focuses on a broad, diversified portfolio across multiple therapeutic areas, providing buyers with a more generalized approach to global pharmaceutical access and patient care solutions.

Sun Pharma

Specialty Pharmaceutical ManufacturerEnterprise

Sun Pharma competes with Teva in the specialty and generic segments, particularly within the US and emerging markets. While Teva emphasizes its legacy in complex generic manufacturing, Sun Pharma differentiates itself through aggressive R&D investment in niche specialty segments, offering buyers a more specialized, high-growth alternative for complex therapeutic drug delivery.

Hikma Pharmaceuticals

Injectable and Generic ManufacturerEnterprise

Hikma competes with Teva in the injectable and generic drug space, focusing heavily on hospital-based products. Unlike Teva’s expansive retail pharmacy presence, Hikma provides a more targeted advantage for institutional buyers, emphasizing high-quality, reliable supply chains for critical care injectables that are essential for hospital and clinical pharmacy operations.

Amneal Pharmaceuticals

Generic and Specialty PharmaEnterprise

Amneal competes with Teva in the generic drug market, specifically targeting complex dosage forms. While Teva operates as a massive, multi-national conglomerate, Amneal offers a more agile, customer-centric service model, providing buyers with faster response times and a more personalized approach to supply chain management for difficult-to-manufacture generic pharmaceutical products.

Unlock Full Company Details and Decision-Maker Insights

Tech stack categories related to Teva

These categories highlight how platforms are organized within the tech stack according to their key capabilities and use cases.

Hospital Injectable Supply

Manufacturing and distribution of sterile injectable medications for clinical settings.

Specialty Pharmaceutical Development

Research and manufacturing of complex, high-value therapeutic drug treatments.

Generic Drug Manufacturing

Large-scale production of off-patent medications for global healthcare markets.

Market overview

The pharmaceutical manufacturing market is defined by intense competition between massive generic conglomerates and specialized R&D-focused firms. Key decision factors for buyers include supply chain resilience, regulatory compliance history, and the ability to provide complex, high-barrier-to-entry medications at scale. Explore Teva’s funding and financial details.

Why users choose Teva

  • Unmatched global scale and distribution network
  • Extensive portfolio of complex generic medications
  • Deep expertise in CNS and respiratory therapeutic areas
  • Long-standing reputation for regulatory reliability

Why users switch to alternatives

  • Desire for more agile, personalized customer service
  • Need for specialized focus on niche therapeutic segments
  • Seeking lower pricing through smaller, more efficient manufacturers
  • Requirement for specific regional supply chain advantages

Discover competitor landscapes for other companies

Ile De Beaute
Beauty RetailerEnterprise

Ile De Beaute is a prominent Russian beauty retailer specializing in premium cosmetics, fragrances, and skincare products. As consumers navigate the competitive landscape of beauty retail, they often look for alternatives that offer better loyalty programs, wider brand exclusivity, or more modern digital shopping experiences. Comparing Ile De Beaute to other market leaders helps shoppers identify which platform best aligns with their specific beauty needs, budget, and service expectations. Whether you are seeking luxury brand access or competitive pricing, understanding these alternatives is essential for making an informed purchasing decision in the evolving Russian beauty market.

Upbound Group
Lease-to-Own Retail ServicesEnterprise

Upbound Group Inc is a diversified conglomerate primarily known for its leadership in the lease-to-own retail sector, providing financial solutions and consumer goods to underserved markets. As the company evolves its fintech capabilities and retail footprint, businesses and investors often look for competitors and alternatives to benchmark its performance. Whether you are evaluating lease-to-own providers or broader financial service conglomerates, comparing Upbound against industry peers is essential for understanding market positioning. This analysis explores the top competitors, highlighting how their specific service models, digital integrations, and retail strategies differ from Upbound Group's established operational framework.

CMHA National
Mental Health Advocacy OrganizationEnterprise

CMHA National is a leading Canadian organization dedicated to promoting mental health and supporting people experiencing mental illness through community-based advocacy and services. As users seek the most effective mental health resources, they often compare CMHA National with other national advocacy groups, clinical research institutions, and digital support platforms. Understanding these alternatives is essential for identifying the right level of care, whether you require local community support, specialized clinical treatment, or immediate digital crisis intervention. This guide helps you compare CMHA National against key competitors to determine which organization best aligns with your specific mental health needs and advocacy goals.

Grupo Cibest
Financial Services ProviderEnterprise

Grupo Cibest SA is a financial services firm providing specialized advisory, investment, and corporate financial solutions. As businesses seek to optimize their capital structure and navigate complex market environments, they often compare Grupo Cibest SA against established banking institutions and specialized financial consultancies. Understanding these competitors is essential for stakeholders evaluating the best partner for financial growth, risk management, and corporate strategy. This analysis explores the top alternatives to Grupo Cibest SA, highlighting how different providers balance personalized advisory services with global banking infrastructure, digital innovation, and specialized investment capabilities to meet the diverse needs of modern corporate and individual clients.

Opaa! Food Management
K-12 Food Service ManagementEnterprise

Opaa! Food Management Inc is a specialized provider of K-12 food service management, focusing on delivering nutritious, community-focused dining programs to school districts. By managing the complexities of menu planning, regulatory compliance, and staff training, they help schools improve student participation and health outcomes. Because school districts must balance strict budgetary constraints with evolving nutritional standards, administrators frequently research competitors and alternatives to ensure they are receiving the best value and service quality. Comparing Opaa! against other industry leaders helps stakeholders evaluate whether a regional, community-centric model or a larger, national-scale provider better aligns with their specific district goals and operational requirements.

Esg Holdings
ESG Investment ConglomerateEnterprise

Esg Holdings Inc operates as a diversified conglomerate with a core focus on integrating environmental, social, and governance (ESG) principles into its investment and operational strategies. As stakeholders increasingly demand transparency and sustainable growth, organizations often compare Esg Holdings Inc against other investment firms and ESG-focused conglomerates to determine the best fit for their capital allocation. Whether you are looking for specialized renewable infrastructure management or broad-based ESG risk analytics, understanding the landscape of competitors and alternatives is essential for making informed investment decisions. This analysis highlights key players that offer comparable services, helping you evaluate which platform best aligns with your specific sustainability and financial objectives.

Frequently Asked Questions About Teva Competitors

Who are the main competitors of Teva?
The main competitors of Teva include Sandoz, Viatris, and Sun Pharma. Each competitor links to its company profile page.
What are some alternatives to Teva?
Alternatives to Teva include companies such as Sun Pharma, Hikma Pharmaceuticals, and Amneal Pharmaceuticals.
Which companies compete with Teva?
Other companies that compete with Teva include Amneal Pharmaceuticals.